Waystar: The Revenue Guidance Range That Will Decide If This Is Still a Growth Story

Waystar Holding Corp. (WAY) reports second-quarter 2026 earnings after the close on July 29, with analysts expecting continued double-digit growth from the healthcare payment software provider. The central question: can WAY sustain its momentum amid a challenging macro backdrop marked by political uncertainty and shifting investor sentiment? With the stock trading well below its 200-day moving average and technical signals weakening, this report will test whether operational execution can overcome broader market headwinds.

Part 1: Earnings Preview

Waystar Holding Corp. provides cloud-based software solutions for healthcare payment processing, serving hospitals, health systems, and physician practices across revenue cycle management and payment workflows. The company's platform automates claims management, payment processing, and patient billing, positioning it as critical infrastructure in the $4 trillion U.S. healthcare payments market.

WAY is expected to report second-quarter earnings after the close on July 29, with the consensus estimate calling for $0.35 per share on revenue expectations that are not disclosed in available data. The company most recently reported $0.37 per share for the first quarter of 2026, beating estimates by 5.71%. Compared to the same quarter last year when WAY earned $0.31 per share, the current estimate of $0.35 represents year-over-year growth of +12.90%, reflecting continued momentum in the business.

Three key themes define this earnings story:

Healthcare IT Demand Resilience: Despite broader economic uncertainty, healthcare payment infrastructure remains mission-critical, with providers increasingly dependent on automation to manage complex reimbursement workflows. Investors will watch for commentary on new customer wins and expansion within existing accounts as indicators of sustained demand.

Margin Expansion Trajectory: As a relatively young public company, WAY's ability to scale efficiently while investing in product development will be scrutinized. Analysts are focused on whether the company can maintain its growth rate while improving profitability metrics.

Macro and Political Headwinds: With President Trump's approval rating hitting record lows—driven by tariff policies that have generated -29 net approval on global trade—and broader market volatility, investors are questioning whether discretionary IT spending in healthcare will face pressure. Any guidance commentary on deal cycles or budget scrutiny will be closely parsed.

Leading analysts remain overwhelmingly bullish heading into the print. The 22 Strong Buy ratings (up from 21 a month ago) reflect confidence in WAY's competitive positioning and growth trajectory, with the mean price target of $33.46 implying significant upside from current levels. However, the recent deterioration in technical signals and the stock's underperformance relative to its 200-day moving average suggest some investors are taking a more cautious stance ahead of the release.

Part 2: Historical Earnings Performance

WAY has demonstrated a mixed but generally positive earnings track record over the past four quarters. The company has beaten consensus estimates in three of the last four reports, with surprises of +3.33%, +6.67%, and +5.71% in June 2025, September 2025, and March 2026, respectively. The lone miss came in December 2025, when WAY reported $0.31 against a $0.35 estimate, an -11.43% shortfall that stands out as an anomaly in an otherwise consistent pattern of outperformance.

The magnitude of beats has been modest but steady, typically in the 3-7% range, suggesting the company and its analyst base have developed a reasonable calibration of expectations. The December miss appears to have been a one-time event, as WAY quickly returned to form with a solid beat in the following quarter. This pattern indicates operational consistency with occasional execution hiccups—a profile that should give investors confidence heading into tomorrow's report, though the December experience serves as a reminder that misses can happen.

Looking at the sequential trend in reported results, WAY has shown relative stability, with EPS ranging between $0.31 and $0.37 over the past year. The most recent quarter's $0.37 represents the high-water mark in this period, suggesting positive momentum heading into the current report. If WAY can deliver on or above the $0.35 consensus, it would mark the fourth beat in five quarters and reinforce confidence in the company's ability to execute consistently.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

WAY reports after the market close, meaning Day 0 captures anticipatory trading before results are released, while Day +1 reflects the market's first full session to digest the actual numbers.

WAY has exhibited highly volatile post-earnings price action, with an average absolute Day +1 move of 7.15% and an average Day +1 range of 9.01%—significantly larger than the Day 0 metrics of 1.61% and 6.83%, respectively. This pattern is consistent with an after-hours reporter: muted anticipatory movement on earnings day itself, followed by sharp reactions once results and guidance are digested.

The direction of moves has been mixed but skewed negative in recent reports. The most dramatic reaction came after the April 2026 report, when the stock plunged 15.41% on Day +1 despite a modest +0.16% Day 0 move, suggesting either a significant miss, weak guidance, or both. Conversely, the February 2026 report triggered a strong +8.48% Day 0 move and a +4.52% Day +1 follow-through, demonstrating the stock's capacity for sharp upside when results exceed expectations. The wide Day +1 ranges—often exceeding 10%—underscore the binary nature of WAY's earnings reactions, where investors should be prepared for significant volatility in either direction.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 8.97% for the August expiration, which is slightly above the historical average Day +1 move of 7.15% but well within the typical range given that several recent reports have triggered double-digit swings. This suggests options traders are anticipating elevated volatility consistent with WAY's recent history, though not pricing in an extreme outlier event.

Part 3: What Analysts Are Saying

Analyst sentiment on WAY remains strongly bullish, with the current consensus rating of 4.77 out of 5.0 reflecting near-universal confidence in the stock. The breakdown shows 22 Strong Buy ratings, 2 Moderate Buys, and 2 Holds, with zero sell ratings across the coverage universe of 26 analysts. This represents an improved sentiment trend from a month ago, when the count stood at 21 Strong Buys, indicating that at least one analyst has upgraded their stance heading into the earnings release.

The average price target of $33.46 implies 41% upside from the current price of $23.69, with the range of targets spanning from a low of $25.00 to a high of $44.00. The wide dispersion in targets—particularly the $44 bull case—reflects differing views on WAY's long-term growth potential and valuation multiple, but the clustering of Strong Buy ratings suggests broad agreement that the stock is undervalued at current levels. The fact that even the low-end target of $25.00 still implies 5.5% upside underscores the consensus view that WAY's recent weakness has created an attractive entry point, assuming the company can deliver on earnings and maintain its growth trajectory.

Part 4: Technical Picture

WAY's technical setup heading into earnings is deteriorating rapidly, with the Barchart Technical Opinion shifting from a 56% Sell signal last week to just an 8% Sell signal currently—a dramatic weakening that suggests the stock is losing downside momentum but has not yet established a clear directional bias. A month ago, the signal stood at 88% Sell, indicating the stock was in a pronounced downtrend that has since moderated but not reversed.

Timeframe Analysis:

• Short-term (50% Buy): Neutral-to-slightly-bullish signal suggests near-term momentum has stabilized after recent weakness
• Medium-term (50% Sell): Neutral-to-slightly-bearish reading indicates consolidation with a modest negative bias in the intermediate timeframe
• Long-term (50% Sell): Neutral-to-slightly-bearish signal reflects lingering weakness in the longer-term trend structure

The trend is characterized as Weak and Weakening, indicating WAY lacks strong directional conviction and is vulnerable to sharp moves in either direction—a setup that amplifies earnings risk.

The stock is currently trading at $23.69, positioned above its 5-day ($22.34), 10-day ($22.34), 20-day ($22.51), 50-day ($20.51), and 100-day ($22.01) moving averages, but critically below its 200-day moving average of $27.02. This configuration suggests WAY has bounced from recent lows and established short-term support, but remains in a longer-term downtrend with significant overhead resistance.

The 200-day moving average at $27.02 represents a key technical hurdle roughly 14% above current levels, while the cluster of shorter-term moving averages in the $20-$22 range should provide support if the stock sells off post-earnings. The weak and weakening trend characteristics, combined with the stock's position below its long-term moving average, create a cautious technical backdrop for the release. However, the recent stabilization in shorter-term momentum and the dramatic shift from 88% Sell to 8% Sell over the past month suggests the worst of the selling pressure may have abated, potentially setting up for a constructive reaction if WAY can deliver a solid beat and guidance.